セッション詳細
[WS(P)27]Tolerance and immune suppression for disease control.
2024年12月5日(木) 15:00 〜 15:45
Poster 5
[WS27-01-O/P]Orally induced tolerance of DTH depends on the inhibition of sensitization in skin-dLNs by integrin α4β7+ T cells derived from mesenteric LNs
○Arisa Akagi1, Rintaro Shibuya2, Sho Hanakawa3, Akihiko Kitoh1, Kenji Kabashima1,3 (1.Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2.Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York City, NY, United States, 3.Skin Research Labs, Agency for Science, Technology and Research (A*STAR), Republic of Singapore)
[WS27-02-O/P]Neural repair and suppression of progression via modulation of microglia by tissue effector Tregs that maintain remission in experimental autoimmune encephalomyelitis
○Youwei Lin1,2, Takashi Yamamura1 (1.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 2.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry)
[WS27-03-O/P]Irradiation conditioning with head shielding protects allogeneic recipients against acute graft-versus-host disease
○Ismael Chatita Adolf1, Sayuri Nakata1, Takanori Teshima2, Hitoshi Takizawa1,3 (1.Laboratory of Stem Cell Stress, International Research Center for Medical Sciences, Kumamoto Univ, Kumamoto, 2.Department of Hematology, Hokkaido Univ Graduate School of Medicine, Sapporo, 3.Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto Univ, Kumamoto)
[WS27-04-O/P]Both the increased expression of PD-1 and the production of humoral factors in stem cells from human exfoliated deciduous teeth reduce the damaging effects of peripheral blood mononuclear cells on human insulin-producing cells.
○Kenta Iwasaki (Department of Kidney disease and Transplant Immunology, Aichi Medical University School of Medicine)
[WS27-05-O/P]iPSCs engrafted in allogeneic hosts without immunosuppression induce donor-specific tolerance to secondary allografts
○Tomoki Kamatani1, Reiko Kimura1, Satoshi Ikeda2, Makoto Inoue2, Ken-ichiro Seino1 (1.Hokkaido Univ., 2.Sumitomo Pharma, Co., Ltd.)
[WS27-06-O/P]Disulfiram treatment inhibits antibody-mediated transplant rejection by suppressing macrophage activation and B-cell pyrimidine metabolism.
○Etsuko Toda1,2, Weili Chen1, Kazuhiro Takeuchi3,1, Shinobu Kunugi1, Mika Terasaki1, Yasuhiro Terasaki1, Yuya Terashima2, Akira Shimizu1 (1.Nippon Medical School, 2.Tokyo University of Science, 3.Kagoshima Univ.)
[WS27-07-O/P]Targeting High CD86 Expression in CD8 T Cells to Enhance Antitumor Immunity in the Tumor Microenvironment
○Xin Hu1, Yifang Shui1,2, Weitao Que1, Yixian Fan1, Masayuki Fujino1,3, Xiao-Kang Li1 (1.National Research Institute for Child Health and Development, 2.The First Affiliated Hospital of Zhengzhou University, 3.National Institute of Infectious Diseases)
[WS27-08-P]Toxoplasma IST suppresses inflammatory and apoptotic response in cytokine-stimulated hepatocytes
○EUN HEE SHIN1,2,3, Seung-Hwan Seo2, Ji-Eun Lee1, Do-Won Ham1 (1.Seoul National University College of Medicine, 2.Seoul National University Institute of Endemic Diseases, 3.Seoul National University Bundang Hospital)
[WS27-09-P]Implications of TIGIT expression and maintenance in suppressing activated T cells
○Naoko Negishi, Jiro Kitaura, Ko Okumura, Sonoko Habu (Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine)
[WS27-10-P]Propofol suppresses antibody production in a T cell-dependent manner
○Susumu Hiraoka1,2, Hiroki Satooka1, Takako Hirata1 (1.Department of Fundamental Biosciences, Shiga University of Medical Science, 2.Department of Anesthesiology, Shiga University of Medical Science)
[WS27-11-P]Suppression of antigen specific T cell responses by LAG-3 agonism
○Taisuke Narazaki, Daisuke Sugiura, Il-mi Okazaki, Takumi Maruhashi, Kenji Shimizu, Taku Okazaki (Laboratory of Molecular Immunology, Institute for Quantitative Biosciences, The University of Tokyo)
[WS27-12-P]Sexual Function Deterioration Among Donor and Recipients after Living-Donor Lobar Lung Transplantation (LDLLT) Procedure: A Systematic Review
○Ester Marnita Purba1,2, Wahyuni Kurniawati3,2, Rosinta H. P. Purba2, Lintong Hottua Simbolon2 (1.Hospitality and Care, Raff Tindal NT, Australia, 2.Department of Socioeconomics and Health Research, The Pranala Institute, Indonesia, 3.Department of Medical Analyst, Incision Care, Egypt)
[WS27-13-P]The effects of immune response and Oxytocin on ischemic resistance
○Ako Matsui, Yoshihiro Harada, Mio Kawazoe, Minako Ito (Division of Allergy and Immunology, Medical Institute of Bioregulation, Kyushu University)
[WS27-14-P]Neuromodulation in patients with epilepsy
○Hiroki Tanaka1, Kaoru Murakami1, Chenfung Lee1, Takeshi Yamasaki2, Rie Hasebe2, Masaaki Murakami1,2,3 (1.Institute for Genetic Medicine, Hokkaido University, 2.National Institute for Physiological Science, 3.National Institute for Quantam and Radiological Science and Techlonogy)